Back to News Research News and Information

Current Research News

    26 August 2015

  1. [New!] Caesarean section per se does not increase the risk of offspring developing type 1 diabetes: a Swedish population-based study.
  2. [New!] Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression.
  3. [New!] Proteomic Analysis of Disease Stratified Human Pancreas Tissue Indicates Unique Signature of Type 1 Diabetes. Free full text available in HTML and PDF formats.

    19 August 2015

  4. Type 1 Diabetes Modifies Brain Activation in Young Patients While Performing Visuospatial Working Memory Tasks.
  5. Extreme Beta-Cell Deficiency in Pancreata of Dogs with Canine Diabetes. Free full text available in PDF format. See also Penn/Baylor Med Study Describes Underlying Cause of Diabetes in Dogs.
  6. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.

    12 August 2015

  7. Feasibility of screening for T1D and celiac disease in a pediatric clinic settin.
  8. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
  9. Influenza A virus antibodies show no association with pancreatic islet autoantibodies in children genetically predisposed to type 1 diabetes.
  10. Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy. Free full text available in HTML and PDF formats.
  11. Kidney Dysfunction in Adult Offspring Exposed In Utero to Type 1 Diabetes Is Associated with Alterations in Genome-Wide DNA Methylation. Free full text available in HTML and PDF formats.
  12. Urinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes. Free full text available in HTML Reader format.

    5 August 2015

  13. Artificial Pancreas Updates From ADA (July 2015).
  14. Multisite Study of an Implanted Continuous Glucose Sensor Over 90 Days in Patients With Diabetes Mellitus.
  15. Regular peaks and troughs in the Australian incidence of childhood type 1 diabetes mellitus (2000-2011).

    29 July 2015

  16. Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention.
  17. Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial.
  18. Infant Feeding and Timing of Complementary Foods in the Development of Type 1 Diabetes.

    22 July 2015

  19. Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.
  20. Long-Term Immunosuppression After Solitary Islet Transplantation Is Associated With Preserved C-Peptide Secretion for More Than a Decade.
  21. Trends in Incidence Rates during 1999-2008 and Prevalence in 2008 of Childhood Type 1 Diabetes Mellitus in GERMANY - Model-Based National Estimates. Free full text available in HTML and PDF formats.
  22. Explaining the increased mortality in type 1 diabetes. Free full text available in HTML and PDF formats.
  23. An observational study of patient characteristics and mortality following hypoglycemia in the community. Free full text available in HTML and PDF formats.
  24. Long-Term Home Study on Nocturnal Hypoglycemic Alarms Using a New Fully Implantable Continuous Glucose Monitoring System in Type 1 Diabetes.
  25. Alpha-Lipoic Acid and Antioxidant Diet Help to Improve Endothelial Dysfunction in Adolescents with Type 1 Diabetes: A Pilot Trial. Free full text available in HTML and PDF formats.

    15 July 2015

  26. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.
  27. Early Detection of Physical Activity for People With Type 1 Diabetes Mellitus.
  28. Inhaled Formoterol Diminishes Insulin-Induced Hypoglycemia in Type 1 Diabetes. See also Inhaled Formoterol Prevents Hypoglycemia in Diabetes Study.
  29. Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 Diabetes.
  30. The Role of Markers of Low-Grade Inflammation for the Early Time Course of Glycemic Control, Glucose Disappearance Rate, and beta-Cell Function in Recently Diagnosed Type 1 and Type 2 Diabetes.
  31. Dietary intake of soluble fiber and risk of islet autoimmunity by 5 y of age: results from the TEDDY study.
  32. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.

    1 July 2015

  33. Parasitic helminths and their beneficial impact on type 1 and type 2 diabetes.
  34. Nocturnal Glucose Metabolism in Type 1 Diabetes: A Study Comparing Single Versus Dual Tracer Approaches.
  35. Compromised immune response in infants at risk for type 1 diabetes born by Caesarean Section.
  36. Maternal VDR variants rather than 25-hydroxyvitamin D concentration during early pregnancy are associated with type 1 diabetes in the offspring.
  37. Ethnic differences in the incidence of type 1 diabetes in Norway: a register-based study using data from the period 2002-200.
  38. A comprehensive review of the pharmacodynamics of the SGLT2 inhibitor empagliflozin in animals and humans.

    24 June 2015

  39. Alterations in Intestinal Microbiota Correlate with Susceptibility to Type 1 Diabetes.
  40. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. See also Smart insulin patch could replace painful injections for diabetes.
  41. Insulin Delivery into the Peripheral Circulation: a Key Contributor to Hypoglycemia in Type 1 Diabetes.
  42. New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4).
  43. Long-Term Control of Diabetes in Immunosuppressed Nonhuman Primates (NHP) by the Transplantation of Adult Porcine Islets.
  44. Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1).
  45. A run on the biobank: what have we learned about type 1 diabetes from the nPOD tissue repository?
  46. Lipoprotein subfraction cholesterol distribution is more atherogenic in insulin resistant adolescents with type 1 diabetes.
  47. Sustained treatment with a stable long-acting oxyntomodulin analogue improves metabolic control and islet morphology in an experimental model of type 1 diabetes.

    17 June 2015

  48. Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial.
  49. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial. See also Which artificial pancreas system is the best for children with type 1 diabetes?
  50. Artificial Pancreas (AP) Technology Take the Stage at the 75th Annual American Diabetes Association (ADA) Conference.
  51. Hope Ahead? Varying Approaches Progress Artificial Pancreas.
  52. Bionic pancreas effective therapy in preadolescent summer camp setting.
  53. Non-HLA gene effects on the disease process of type 1 diabetes: From HLA susceptibility to overt disease.
  54. Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus.
  55. Common Sequence Variation in the VEGFC Gene Is Associated with Diabetic Retinopathy and Diabetic Macular Edema.
  56. Family history and ethnicity influencing clinical presentation of type 1 diabetes in childhood.
  57. Parents' experiences 12 years after newborn screening for genetic susceptibility to type 1 diabetes and their attitudes to whole-genome sequencing in newborns.
  58. Extreme Beta-Cell Deficiency in Pancreata of Dogs with Canine Diabetes. Free full text available in HTML and PDF formats.

    10 June 2015

  59. Sugar intake is associated with progression from islet autoimmunity to type 1 diabetes: the Diabetes Autoimmunity Study in the Young.
  60. Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. Free full text available in PDF format.
  61. Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp. Free full text available in PDF format.
  62. Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes. Free full text available in PDF format.
  63. Glucagon - the new 'insulin' in the pathophysiology of diabetes.

    3 June 2015

  64. Fabrication of three-dimensional bioplotted hydrogel scaffolds for islets of Langerhans transplantation. See also 3D-printed scaffolds may make for improved diabetes treatment.
  65. Stable Incretin Mimetics Counter Rapid Deterioration of Bone Quality in Type 1 Diabetes Mellitus.
  66. Gestational and Early Infancy Exposure to Margarine Fortified with Vitamin D through a National Danish Programme and the Risk of Type 1 Diabetes: The D-Tect Study. Free full text available in HTML and PDF formats.
  67. Vitamin D levels at birth and risk of type 1 diabetes in childhood: a case-control study.

    27 May 2015

  68. Association between hypoglycaemia and impaired hypoglycaemia awareness and mortality in people with Type 1 diabetes mellitus.
  69. Infrared thermographic assessment of changes in skin temperature during hypoglycaemia in patients with type 1 diabetes.
  70. Magnetic resonance imaging reveals altered distribution of hepatic fat in children with type 1 diabetes compared to controls.
  71. Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.
  72. Treatment of diabetes with encapsulated pig islets: an update on current developments. Free full text available in HTML and PDF formats.
  73. Behavioral economics survey of patients with type 1 and type 2 diabetes. Free full text available in HTML and PDF formats.

    20 May 2015

  74. Stem cells for the cell and molecular therapy of type 1 diabetes mellitus (T1D): the gap between dream and reality. Free full text available in HTML and PDF formats.
  75. Efficacy and Safety of LY2963016 Insulin Glargine Compared with Insulin Glargine (LantusŪ) in Patients with Type 1 Diabetes in a Randomised Controlled Trial (The ELEMENT 1 Study).
  76. Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes. Free full text available in HTML and PDF formats.
  77. Lipid peroxidation and antioxidant protection in girls with type 1 diabetes mellitus during reproductive system development. Free full text available in HTML and PDF formats.
  78. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. Free full text available in HTML and PDF formats.

    13 May 2015

  79. Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial.
  80. A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes.

    6 May 2015

  81. Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates. See also Experimental 'Smart' Insulin Shows Promise in Mice: Study.
  82. In-silico Closed Loop Control Validation Studies for Optimal Insulin Delivery in Type 1 Diabetes.
  83. Clinical results of islet transplantation.

    29 April 2015

  84. Clinical Results of an Automated Artificial Pancreas Using Technosphere Inhaled Insulin to Mimic First-Phase Insulin Secretion.
  85. Type 1 diabetes: A predictable disease. Free full text available in HTML and PDF formats.
  86. Efficacy of a long-acting c-peptide analogue against peripheral neuropathy in streptozotocin-diabetic mice.
  87. Glycemia, Hypoglycemia, and Costs of Simultaneous Islet-Kidney or Islet After Kidney Transplantation Versus Intensive Insulin Therapy and Waiting List for Islet Transplantation.
  88. White matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetes.
  89. Living Donor Kidney Transplantation Preceding Pancreas Transplantation Reduces Mortality in Type 1 Diabetics With End-stage Renal Disease.
  90. Straylight, lens yellowing and aberrations of eyes in Type 1 diabetes. Free full text available in HTML and PDF formats.

    22 April 2015

  91. A prevascularized subcutaneous device-less site for islet and cellular transplantation.
  92. Effects of High-Dose Oral Insulin on Immune Responses in Children at High Risk for Type 1 Diabetes.
  93. Daycare attendance, breastfeeding, and the development of type 1 diabetes: the diabetes autoimmunity study in the young. Free full text available in HTML and PDF formats.
  94. Environmental Trigger(s) of Type 1 Diabetes: Why So Difficult to Identify? Free full text available in HTML and PDF formats.
  95. Can Exposure to Environmental Chemicals Increase the Risk of Diabetes Type 1 Development? Free full text available in HTML and PDF formats.
  96. Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications. Free full text available in HTML and PDF formats.
  97. Computer Vision-Based Carbohydrate Estimation for Type 1 Diabetic Patients Using Smartphones.
  98. New technologies in diabetology : How far are we from a closed loop?
  99. A method for reporting and classifying acute infectious diseases in a prospective study of young children: TEDDY. Free full text available in HTML and PDF formats.
  100. Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery. Free full text available in HTML and PDF formats.
  101. Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D). Free full text available in HTML and PDF formats.

    15 April 2015

  102. Experience of a serious life event increases the risk for childhood type 1 diabetes: the ABIS population-based prospective cohort study. See also Serious life events in childhood can triple risk of developing type 1 diabetes.
  103. Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. Free full text available in HTML and PDF formats.
  104. Continuous Intraperitoneal Insulin Infusion Versus Subcutaneous Insulin Therapy in the Treatment of Type 1 Diabetes: Effects on Glycemic Variability.
  105. Assessment of the relationship between hypoglycaemia awareness and autonomic function following islet cell/pancreas transplantation.
  106. Corneal Confocal Microscopy Detects Neuropathy in Patients with Type 1 Diabetes without Retinopathy or Microalbuminuria. Free full text available in HTML and PDF formats.
  107. Quantification of Diabetes Comorbidity Risks across Life Using Nation-Wide Big Claims Data. Free full text available in HTML and PDF formats.
  108. Distinct methylation patterns in genes that affect mitochondrial function are associated with kidney disease in blood-derived DNA from individuals with Type 1 diabetes.

    8 April 2015

  109. Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes-a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study will add to the knowledge of the use of GLP-1 receptor agonists in people with type 1 diabetes.
  110. Sodium glucose transporter 2 (sglt2) inhibitors: Current status in clinical practice.
  111. Perinatal and childhood risk factors for early-onset type 1 diabetes: a population-based case-control study in Taiwan.
  112. Lower serum 25 (OH) D concentrations in type 1 diabetes: A meta-analysis.

    2 April 2015

  113. Validity of animal models of type 1 diabetes, and strategies to enhance their utility in translational research.
  114. Bioengineered stem cells as an alternative for islet cell transplantation. Free full text available in HTML and PDF formats.
  115. Epidemiologic Features of Type 1 Diabetic Patients between 0 and 18 Years of Age in İstanbul City.
  116. Low mean temperature rather than few sunshine hours are associated with an increased incidence of type 1 diabetes in children.

[ Current Research News | News from 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]

  Home Return to Top

Last Updated: Wednesday August 26, 2015 18:21:02
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.